ALFA FinderBSE filing, NSE: PPL. Summary written from the filing by ALFA Finder's alert engine.
Prakash Pipes Ltd: key numbers
- Share price
- ₹228.59
- Market cap
- ₹546.8 Cr
- Revenue (annual)
- ₹788.7 Cr
- Net profit (annual)
- ₹43.26 Cr
- P/E (TTM)
- 11.1×Sector 51.9×
- Promoter holding
- 44.50%+0.00% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prakash Pipes Ltd
All →Prakash Pipes Q2 FY27 Results: Net Profit ₹16.1 Cr, Up 71.3% YoY
Prakash Pipes Ltd reported revenue from operations of ₹259.1 Cr (+43.1% YoY) and net profit of ₹16.1 Cr (+71.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹16.1 Cr · +71.3% YoY
Prakash Pipes Board Meeting Date
Prakash Pipes scheduled a board meeting on November 12, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are made public.
Prakash Pipes Other Announcement
Prakash Pipes Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Prakash Pipes Management Change
Mr. Jagdish Chandra has resigned from the position of Company Secretary and Compliance Officer of Prakash Pipes Limited, effective October 17, 2026.
Prakash Pipes Annual General Meeting
Prakash Pipes Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, dividend, director re-appointment, and cost auditor remuneration.
Prakash Pipes Annual Report
Prakash Pipes Limited has filed its Annual Report for the financial year 2025-26 along with the notice of its 9th Annual General Meeting.
Other results update announcements
All →Niyogin Fintech Results Update
Niyogin Fintech's CEO letter reports Q2 FY27 net revenue of Rs 23.9 Cr and PBT ex-ESOP loss of Rs 4.4 Cr. Composite scheme awaits final NCLT approval.
Gaudium IVF And Women Health Results Update
Gaudium IVF reported Q2 FY27 revenue of ₹37.4 crore, up 17.9% YoY, with H1 revenue at ₹56.8 crore. Two new IVF hubs commenced operations during the quarter.
Systematix Corporate Services Results Update
Systematix's Q2 FY27 adjusted revenue rose 102% QoQ to ₹56.04 crore, with PAT of ₹13.13 crore. Year-on-year revenue was flat, while H1 PAT fell to ₹8.24 crore.
TARC Results Update
TARC reported H1 FY2027 total income of ₹352.78 crore and PAT of ₹27 crore. Q2 PAT was ₹4.05 crore, versus a loss in Q2 FY2026.
Balaxi Pharmaceuticals Results Update
Balaxi Pharmaceuticals issued a press release on Q2 FY27 results, with revenue up 45% and PAT up 450% year-on-year. EBITDA rose 338% to ₹512.07 lakh.
Q-Line Biotech Results Update
Q-Line Biotech's H1 FY27 revenue rose 5.83% while EBITDA grew 10.02%, but PAT fell 8.06%. The release also covers a proposed 70% stake acquisition in Heidelco.